<DOC>
	<DOCNO>NCT00811915</DOCNO>
	<brief_summary>The use tacrolimus long term part immunosuppressive regimen transplantation associate complication chronic nephrotoxicity , impair glucose metabolism ( diabetes mellitus ) increase incidence neoplasia . The conversion tacrolimus base therapy sirolimus base therapy associate mycophenolate mofetil could improve incidence complication . The aim study assess risk/benefit ratio switch perform stable renal transplant recipient 12 month 36 month transplantation . The incidence composite endpoint ( worsen GFR evaluate MDRD formula , incidence cancer diabetes ) assess 24 month conversion .</brief_summary>
	<brief_title>Study Compare Safety Efficacy Sirolimus ( Rapamune ) Tacrolimus ( Advagraf ) Associated Mycophenolate Mofetil ( CellCept ) Between 12 36 Months After Kidney Transplantation</brief_title>
	<detailed_description>Two dos Sirolimus evaluate accord CYP 3A5 genotype . Patients carry least CYP 3A5 *1 allele receive 4 mg per day whereas others ( CYP 3A5 *3/*3 ) receive 2 mg .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Recipient age ≥18 ≤ 75 an . Patients receive first second renal transplant cadaveric living relate donor 12 24 month prior inclusion . Peak panel reactive antibody ( PRA ) &lt; 30 % Patients stable renal function 3 month prior inclusion ( variation serum creatinine low 20 % ) Creatinine clearance ≥ 40 ml/mn/1.73 m26 . Patients receive stable immunosuppressive treatment associating : Mycophenolate mofetil ( MPA AUC &gt; 30 mg.h/L ) Tacrolimus trough level &gt; 4 ng/ml , without corticoid Multiorgan recipients Patients receive cyclosporine Pregnancy Recipients ABO incompatible graft Use immunosuppressive drug . Historical peak reactive antibody ≥ 30 % Past medical history humoral rejection , 2 episode acute cellular rejection Past medical history subclinical rejection routine allograft biopsy Calculated creatinine clearance &lt; 40 ml/mn/1.73 m2 24h proteinuria &gt; 1 g/24H Patients severe diarrhea HTLV1 HIV positivity Known hypersensitivity tacrolimus , mycophenolate mofetil , sirolimus . Total white blood cell &lt; 2500/mm3 hemoglobin &lt; 9 g/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Sirolimus</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Kidney Transplant Recipients</keyword>
</DOC>